PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Namur Institute for Complex System (naXys) and Department of Mathematics, University of Namur, Namur, Belgium.\', \'Department of Infectious Diseases, Centre Hospitalier Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium.\', \'Environmental Health Research Centre, Public Health School, Université Libre de Bruxelles (ULB), Brussels, Belgium.\', \'Belgian Federal Agency for Medicines and Health Products, Brussels, Belgium.\', \'Namur Thrombosis and Hemostasis Center, Department of Pharmacy, University of Namur, Namur, Belgium.\', \'Faculty of Pharmaceutical Sciences, University of Lubumbashi, Lubumbashi, DR Congo.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/bcp.14436
?:doi
?:hasPublicationType
?:journal
  • British journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32559820
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.543
?:rankingScore_hIndex
  • 126
is ?:relation_isRelatedTo_publication of
?:title
  • Model informed dosing of hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and gaps.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all